Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Gropp Chris PSenior Vice President and CFO | Grant or award | A | — 9 sh | Sep 21, 2026 |
| 5 | Stolove EvanEVP, Gen. Counsel & Secretary | Grant or award | A | — 21 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 5 | Sousa Mauad BrunoDirector | Derivative conversion | C | $99K 1,100 sh | Sep 21, 2026 traded Sep 18, 2026 |
| 4 | Anderson David HugoDirector | Open-market sale · 10b5-1 plan | SELL | $72K 1,500 sh | Sep 21, 2026 traded Sep 18, 2026 |
| 4 | Lynch Thomas P.See Remarks | Option exercise · 10b5-1 plan | M | $50K 2,920 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 3 | Lynch Thomas P.See Remarks | Option exercise · 10b5-1 plan | M | $80K 6,968 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 3 | Collins Helen LouiseCHIEF MEDICAL OFFICER | Option exercise · 10b5-1 plan | M | $12K 5,000 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 3 | Lynch Thomas P.See Remarks | Option exercise · 10b5-1 plan | M | $180K 5,840 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 2 | Mahdessian AraDirector, Chief Executive Officer | Derivative conversion | C | — 3,148 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 2 | Kuzoyan VaheDirector, President | Derivative conversion | C | — 3,148 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 2 | Sousa Mauad BrunoDirector | Derivative conversion | C | $48K 1,619 sh | Sep 21, 2026 traded Sep 18, 2026 |
| 2 | Hohl BenjaminCHIEF FINANCIAL OFFICER | Option exercise · 10b5-1 plan | M | $59K 3,982 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 2 | Flower JohannaDirector | Grant or award | A | — 56 sh | Sep 21, 2026 traded Sep 18, 2026 |
| 0 | Akinsanya KarenSee Remarks | Option exercise · 10b5-1 plan | M | — 31.6K sh | Sep 21, 2026 traded Sep 17, 2026 |
| 0 | Lynch Thomas P.See Remarks | Option exercise · 10b5-1 plan | M | $180K 5,840 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 0 | Lynch Thomas P.See Remarks | Option exercise · 10b5-1 plan | M | $80K 6,968 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 0 | Hohl BenjaminCHIEF FINANCIAL OFFICER | Option exercise · 10b5-1 plan | M | — 3,982 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 0 | Collins Helen LouiseCHIEF MEDICAL OFFICER | Option exercise · 10b5-1 plan | M | — 5,000 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 0 | Lynch Thomas P.See Remarks | Option exercise · 10b5-1 plan | M | $50K 2,920 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 54 | Adelborg AusteSecretary | Open-market sale | SELL | $613K 6,834 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 54 | Cardenuto Rodolpho CDirector | Open-market sale | SELL | $878K 5,321 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 53 | Avella Christopher JohnChief Financial Officer | Open-market sale | SELL | $4.89M 56.5K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 52 | Shen Ching Hang10% Owner | Open-market purchase | BUY | $5.00M 878.7K sh | Sep 18, 2026 traded Sep 15, 2026 |
| 52 | Mackey Cameron KeyserChief Operating Officer | Open-market sale | SELL | $11.13M 125.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 35 | Budur KumarCHIEF MEDICAL OFFICER | Open-market sale | SELL | $1.54M 35.9K sh | Sep 18, 2026 traded Sep 18, 2026 |
| 35 | Sousa Mauad BrunoDirector | Open-market sale | SELL | $3.77M 40.6K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 34 | Konowiecki Joseph SDirector, EVP, Corporate Affairs | Open-market sale | SELL | $202K 23.5K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 33 | Cox John DDirector | Open-market purchase | BUY | $59K 12.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 32 | Allen William TDirector | Open-market sale | SELL | $241K 26.2K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 32 | Schrenk Troy C.Chief Commercial Officer | Open-market purchase | BUY | $125K 5,907 sh | Sep 18, 2026 traded Sep 18, 2026 |
| 31 | Sousa Mauad BrunoDirector | Open-market sale | SELL | $3.04M 33.2K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 31 | Aviv David MelehChief Technology Officer | Open-market sale | SELL | $461K 15.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 30 | Cislini JeffSVP & General Counsel | Open-market sale · 10b5-1 plan | SELL | $660K 3,314 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 29 | Graves Jeffrey ADirector, President and CEO | Open-market sale | SELL | $152K 42.7K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 29 | Nordstrom Phyllis BEVP, CFO and CAO | Open-market sale | SELL | $107K 30.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 29 | Pete SessionsRSelf | Sale | SELL | $15K – $50K | Sep 18, 2026 traded Sep 14, 2026 |
| 29 | Saunders Scott JDirector | Open-market sale | SELL | $43K 203 sh | Sep 18, 2026 traded Sep 18, 2026 |
| 29 | Kritzmire Anne W.Director | Open-market purchase | BUY | $6,234 300 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 28 | MacKay Craig CDirector | Open-market sale | SELL | $109K 2,000 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 28 | Tannenbaum Leonard MDirector, 10% Owner | Open-market purchase | BUY | $88K 25.0K sh | Sep 18, 2026 traded Sep 17, 2026 |